Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study.

MLA

Beasley, William D., et al. “Reprimo 824 G>C and P53R2 4696 C>G Single Nucleotide Polymorphisms and Colorectal Cancer: A Case-Control Disease Association Study.” International Journal of Colorectal Disease, vol. 23, no. 4, Apr. 2008, pp. 375–81. EBSCOhost, https://doi.org/10.1007/s00384-007-0435-3.

APA

Beasley, W. D., Beynon, J., Jenkins, G. J. S., & Parry, J. M. (2008). Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study. International Journal of Colorectal Disease, 23(4), 375–381. https://doi.org/10.1007/s00384-007-0435-3

Chicago

Beasley, William D, John Beynon, Gareth J S Jenkins, and Jim M Parry. 2008. “Reprimo 824 G>C and P53R2 4696 C>G Single Nucleotide Polymorphisms and Colorectal Cancer: A Case-Control Disease Association Study.” International Journal of Colorectal Disease 23 (4): 375–81. doi:10.1007/s00384-007-0435-3.